药品上市许可持有人在药品全生命周期中安全风险主体责任的探讨
钟露苗
MAHs’ Principal Responsibilities for Safety Risk during the Whole-life Cycle of Drugs
ZHONG Lumiao
中国药物警戒 . 2019, (11): 666 -669 .  DOI: 10.19803/j.1672-8629.2019.11.05